Dopamine and ADHD/ADD – MTHFR, COMT, MAOA & DRD2 Genetic Testing

Product detailed description

The Dopamine and ADHD/ADD Genetic Test analyzes selected inherited genetic variants involved in dopamine metabolism, neurotransmitter signaling, and biological processes important for brain function. Dopamine is a neurotransmitter that enables communication between nerve cells and plays an important role in motivation, attention, learning, reward processing, and behavioral regulation.

The test focuses on four genes – MTHFR, COMT, MAOA, and DRD2, which contribute to different aspects of neurotransmitter metabolism and nervous system function.

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental condition characterized by difficulties with attention, impulsivity, and/or hyperactivity. Some individuals primarily experience attention-related difficulties without pronounced hyperactivity, a presentation previously often referred to as ADD.

Genetics plays an important role in ADHD susceptibility. However, ADHD is a complex condition influenced by many genetic variants and additional biological and environmental factors rather than a single gene.

What does the genetic test analyze?

• COMT – Dopamine metabolism: Genetic variants affecting an enzyme involved in the breakdown of dopamine and other catecholamines. Certain variants may influence enzyme activity.

• MAOA – Neurotransmitter breakdown: A gene encoding monoamine oxidase A, an enzyme involved in the metabolism of dopamine, serotonin, and norepinephrine.

• DRD2 – Dopamine receptors: Genetic factors associated with dopamine D2 receptor function, which contributes to brain signaling, motivation, and reward processing.

• MTHFR – Folate and homocysteine metabolism: Genetic variants involved in vitamin B9 metabolism and methylation pathways important for normal cellular and nervous system function.

Who may benefit from this genetic test?

• Individuals interested in genetic factors associated with dopamine signaling.

• People exploring the genetics of attention, motivation, learning, and brain function.

• Those interested in genetic variants investigated in relation to ADHD.

• Individuals interested in neurogenetics and inherited differences in neurotransmitter metabolism.

• Anyone seeking supplementary information about biological pathways involved in nervous system function.

What can the results reveal?

The MTHFR, COMT, MAOA, and DRD2 genetic test identifies selected inherited variants involved in neurotransmitter metabolism, dopamine receptor signaling, and folate-related biochemical pathways.

Results provide additional insights into genetic differences in biological processes that contribute to normal nervous system function.

Important: This genetic test cannot diagnose or rule out ADHD/ADD, reliably predict an individual's risk of developing ADHD, or determine attention span, motivation, or impulsivity. The tested variants do not directly measure dopamine levels in the brain. Their associations with ADHD are still being investigated, and their clinical usefulness for diagnosis remains limited. The test does not replace psychological, psychiatric, or neurological assessment.